Cytena articles

In GMP cell therapy manufacturing, manual washing introduces variability and increases documentation burden, whereas automated, closed or semi-closed washing enhances recovery, reduces contamination risk, and supports electronic batch records.

In cell therapy, the cell is the product. Each wash step impacts viability and yield. When starting material is limited, even small losses can prevent a batch from meeting release criteria. Washing processes in GMP environments must be repeatable